Imaging revealed diffuse bone metastases, and bone biopsy confirmed a poorly differentiated adenocarcinoma of breast origin (estrogen receptor, 60%; progesterone receptor, 35%; GATA3 positive). This evidence concerns the gene GATA3 and adenocarcinoma.